German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01EE" (17)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Trametinib (L01EE01) 5 products
WHO-DDD
L
IP
CI
PP
Mekinist 0.5 mg
7 Tablet(s)
283.99
325.25
10 %
Coated tablets: Trametinibum
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
PP
Mekinist 0.5 mg
30 Tablet(s)
1217.11
1340.10
10 %
Coated tablets: Trametinibum
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
PP
Mekinist 2 mg
7 Tablet(s)
1135.97
1251.85
10 %
Coated tablets: Trametinibum 2 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
PP
Mekinist 2 mg
30 Tablet(s)
4868.44
5302.80
10 %
Coated tablets: Trametinibum 2 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
CI
Mekinist 4.7 mg
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: Trametinibum 4.7 mg
Novartis Pharma
Schweiz AG
A
FB
G
Cobimetinib (L01EE02) 1 products
WHO-DDD
L
IP
CI
PP
Cotellic 20mg
63 Tablet(s)
4891.99
5327.00
10 %
Coated tablets: Cobimetinibum 20 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Binimetinib (L01EE03) 4 products
WHO-DDD
L
IP
CI
Mektovi 15 mg
84
2147.80
2352.30
10 %
Coated tablets: Binimetinibum 15 mg
Pierre Fabre Pharma SA
A / SL
FB
G
L
IP
CI
Mektovi 15 mg
168
4295.60
4688.15
10 %
Coated tablets: Binimetinibum 15 mg
Pierre Fabre Pharma SA
A / SL
FB
G
L
IP
CI
Mektovi 45 mg
28
2147.80
2352.30
10 %
Coated tablets: Binimetinibum 45 mg
Pierre Fabre Pharma SA
A / SL
FB
G
L
IP
CI
Mektovi 45 mg
56
4295.60
4688.15
10 %
Coated tablets: Binimetinibum 45 mg
Pierre Fabre Pharma SA
A / SL
FB
G
Selumetinib (L01EE04) 2 products
WHO-DDD
L
IP
CI
Koselugo 10 mg
60
4725.14
5155.80
10 %
Capsules: Selumetinibum 10 mg
Alexion Pharma GmbH
A / SL
FB
G
L
IP
CI
Koselugo 25 mg
60
11789.10
12403.40
10 %
Capsules: Selumetinibum 25 mg
Alexion Pharma GmbH
A / SL
FB
G
Mirdametinib (L01EE05) 5 products
WHO-DDD
IP
CI
Ezmekly 1 mg
42
k.A.
Capsules: Mirdametinibum 1 mg
Merck (Schweiz) AG
A
FB
G
IP
Ezmekly 2 mg
42
k.A.
Capsules: Mirdametinibum 2 mg
Merck (Schweiz) AG
A
FB
G
IP
CI
Ezmekly 1 mg
42
k.A.
Tabletten zur Herstellung einer Suspension zum Einnehmen: Mirdametinibum 1 mg
Merck (Schweiz) AG
A
FB
G
IP
Ezmekly 2 mg
84
k.A.
Capsules: Mirdametinibum 2 mg
Merck (Schweiz) AG
A
FB
G
IP
CI
Ezmekly 1 mg
84
k.A.
Tabletten zur Herstellung einer Suspension zum Einnehmen: Mirdametinibum 1 mg
Merck (Schweiz) AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
